Cain Wettan Keeley M 4

What Happened

• Cain Wettan Keeley M, EVP, General Counsel, Legal & Compensation at Gilead Sciences, received an award of 470 shares of Gilead common stock on 2026-02-27. The filing reports the shares were issued at $0.00 (award/grant), so no cash was paid by the insider at issuance.
• The award represents a tranche of performance share awards originally granted March 10, 2025; the performance-vesting condition was certified satisfied on 2026-02-27.

Key Details

• Transaction date: 2026-02-27; Filing date: 2026-03-02 (no late filing indicated in the form).
• Reported transaction: Award/Grant (code A) — 470 shares @ $0.00; reported value $0.
• Footnote: These shares are tranches of the March 10, 2025 performance share awards and were subject to both performance-vesting and service-vesting. Performance vesting was certified by the Compensation and Talent Committee on the reporting date.
• Shares owned after the transaction: not specified in the provided data.

Context

• This was an issuance of performance-based restricted shares (an award vesting upon performance certification and likely still subject to service-vesting), not an open-market purchase or sale — it does not directly signal buying/selling sentiment.
• For retail investors, award grants are routine parts of executive compensation and can reflect previously awarded pay converting to payable shares after meeting performance criteria; they do not involve the insider spending cash to buy stock.